Complexation of ursodeoxycholic acid with β-cyclodextrin-choline dichloride coprecipitate

International Journal of Pharmaceutics

Volumn 190, Issue 2, 1999, Pages 139-153

  Orienti, I ^a   Cerchiara, T ^a   Zecchi, V ^a   Arias Blanco, M J ^b   Gines, J M ^b   Moyano, J R ^b   Rabasco Alvarez, A M ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Cyclodextrin; Cyclodextrin choline dichloride coprecipitate; Characterization of the complexes; Dissolution rate; Solubility studies; Ursodeoxycholic acid

Indexed keywords

BETA CYCLODEXTRIN; CHOLINE DERIVATIVE; URSODEOXYCHOLIC ACID;

ARTICLE; COMPLEX FORMATION; DRUG SOLUBILITY; DRUG STRUCTURE; PH; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TEMPERATURE DEPENDENCE; THERMODYNAMICS;

BETA-CYCLODEXTRINS; CALORIMETRY, DIFFERENTIAL SCANNING; CYCLODEXTRINS; EXCIPIENTS; MAGNETIC RESONANCE SPECTROSCOPY; MICROSCOPY, ELECTRON, SCANNING; SOLUBILITY; SPECTROPHOTOMETRY, INFRARED; THERMODYNAMICS; URSODEOXYCHOLIC ACID; X-RAY DIFFRACTION;

EID: 0032751219     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(99)00205-7     Document Type: Article

References (13)

1. Anguiano-Igea S., Otero-Espinar F.J., Vila-Jato J.L., Blanco-Méndez J. Evaluation of sealed heating method for the obtention of a clofibrate-β-cyclodextrin inclusion complex. Stp Pharma Sci. 2:1992;325-331.
2. Giunchedi P., Scalia S., Maggi L., Conte U. Ursodeoxycholic acid: improvement of dissolution behaviour and its HPLC determination. Int. J. Pharm. 130:1996;41-47.
3. Higuchi T., Connors K.A. Phase-solubility techniques. Adv. Anal. Chem. Instrum. 4:1965;117-212.
4. Igimi H., Carey M.C. pH-Solubility relations of chenodeoxycholic and ursodeoxycholic acids: physical-chemical basis for dissimilar solution and membrane phenomena. J. Lipid Res. 21:1980;72-90.
5. Miyajima K., Yokoi M., Komatsu H., Nakagaki M. Interaction of β-cyclodextrin with bile salts in aqueous solutions. Chem. Pharm. Bull. 34:1986;1395-1398.
6. Moroi Y., Kitagawa M., Itoh H. Aqueous solubility and acidity constant of cholic, deoxycholic, chenodeoxycholic and ursodeoxycholic acids. J. Lipid Res. 33:1992;49-53.
7. Roda A., Gatti R., Cavrini V., Cerrè C., Simoni P. HPLC study of the impurities present in different ursodeoxycholic acid preparations: comparative evaluation of four detectors. J. Pharm. Biomed. Anal. 11:1993;751-760.
8. Roda A., Roda E., Marchi E., Simoni P., Cerrè C., Pistillo A., Polimeni C. Improved intestinal absorption of an enteric-coated sodium ursodeoxycholate formulation. Pharm. Res. 11:1994;642-647.
9. Scalia S., Pazzi P., Stabellini G., Guarneri M. HPLC assay of conjugated bile acids in gastric juice during ursodeoxycholic acid therapy of bile reflux gastritis. J. Pharm. Biomed. Anal. 6:1988;911-917.
10. Scalia S., Pazzi P., Guarnieri M. Determination of bile acid in pharmaceutical dosage forms by HPLC. Anal. Lett. 22:1989;915-927.
11. Simoni P., Cerrè C., Cipolla A., Polimeni C., Pistillo A., Ceschel G., Roda E., Roda A. Bioavailability study of a new, sinking, enteric-coated ursodeoxycholic acid formulation. Pharm. Res. 31:1995;115-119.
12. Vandelli M.A., Salvioli G., Mucci A., Panini R., Malmusi L., Forni F. 2-Hydroxypropyl-β-cyclodextrin complexation with ursodeoxycholic acid. Int. J. Pharm. 118:1995;77-83.
13. Ventura C.A., Tirendi S., Puglisi G., Bousquet E., Panza L. Improvement of water solubility and dissolution rate of ursodeoxycholic acid and chenodeoxycholic acid by complexation with natural and modified β-cyclodextrins. Int. J. Pharm. 149:1997;1-13.